Why the study?
Are one-hour and two-hour postload plasma glucose levels stronger predictors of long-term cardiovascular events compared to fasting glucose and HbA1c?
Are one-hour and two-hour postload plasma glucose levels stronger predictors of long-term cardiovascular events compared to fasting glucose and HbA1c?
This review highlights that postprandial glucose levels are superior to fasting glucose and HbA1c in predicting long-term cardiovascular events and vascular damage.
Answers are grounded in this paper and cite their sources.
Postprandial glucose may refine CV risk assessment; leaves open whether targeting it improves outcomes beyond HbA1c.
This review summarizes the vast literature describing the long-term epidemiological studies with emphasis on postprandial glucose as a stronger predictor of cardiovascular complications as compared to fasting glucose and HbA1c. Many molecular studies also supported this fact by illustrating that postchallenge hyperglycemia is associated with elevated biomarkers of systemic inflammation in the plasma and thus increasing the chances of vascular damage. Large-scale studies have proved that vascular stiffness, brachial-ankle pulse-wave velocity, carotid intima thickness, and left ventricular hypertrophy have been associated with postprandial glucose as compared to fasting glucose or glycosylated hemoglobin.
No takes yet. Share an insight, caveat, or question.
Mann et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: